ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Kidney Week 2020 Reimagined: Webcasts

Speaker Bio

President's Address

Anupam Agarwal, MD, FASN

Date of Event: October 22, 2020
Time: 9:00 AM - 9:30 AM EDT
Session Type: Simulive
Complimentary

Speaker Bio

Anupam Agarwal, MD, FASN is currently Director, Division of Nephrology, and Executive Vice Dean, School of Medicine at the University of Alabama at Birmingham (UAB). He also serves as the Program Director of the NIH/NIDDK funded O'Brien Center for Acute Kidney Injury Research. He has graduate faculty status in the Departments of Biochemistry and Molecular Genetics, Pathology and Cell, Developmental and Integrative Biology at UAB.Dr. Agarwal has an active role in clinical medicine, teaching, research and administration. He is intensively involved in the teaching of medical students, internal medicine house staff and nephrology fellows and has been a recipient of Outstanding Teaching Awards from the Department of Medicine at the University of Florida as well as at UAB. Dr. Agarwal's research program, funded by the NIH and Department of Veterans Affairs, has provided critical insights regarding the protective nature and significance of heme oxygenase-1 (HO-1) in vascular and renal inflammation, angiogenesis, transplant biology, and the molecular regulation of the human HO-1 gene. His bibliography includes 157 peer-reviewed papers and 43 invited reviews/book chapters, the former appearing in journals such as the Journal of the American Society of Nephrology, Journal of Clinical Investigation, JCI Insight, Journal of Experimental Medicine, Proceedings of the National Academy of Sciences, Journal of Biological Chemistry, Circulation, Circulation Research, American Journal of Pathology as well as others. He has been recognized by the Max Cooper award for excellence in research, the Thomas Andreoli Professorship in Nephrology, election to membership in the American Society of Clinical Investigation (ASCI), American Clinical and Climatological Association (ACCA), Association of American Physicians (AAP) the Marie S. Ingalls Endowed Chair in Nephrology leadership, a Dean's Excellence award for leadership and the Graduate Dean's Excellence in Mentorship award at UAB. He is the recipient of the UAB National Alumni Society Honorary Alumnus award and a Laureate Recipient for the Alabama Chapter of the American College of Physicians.

Read more »

View Webcast



Speaker Bio

State-of-the-Art Lecture "Human Genome Editing: Responsible Pathway Forward"

Victor J. Dzau, MD

Date of Event: October 22, 2020
Time: 9:30 AM - 10:00 AM EDT
Session Type: Simulive
Complimentary

Speaker Bio

Victor J. Dzau, MD, is the President of the National Academy of Medicine (NAM), formerly the Institute of Medicine (IOM). In addition, he serves as Vice Chair of the National Research Council. Dr. Dzau is Chancellor Emeritus and James B. Duke Professor of Medicine at Duke University and the past President and CEO of the Duke University Health System. Previously, Dr. Dzau was the Hershey Professor of Theory and Practice of Medicine and Chairman of Medicine at Harvard Medical School's Brigham and Women's Hospital, as well as Chairman of the Department of Medicine at Stanford University. He is an internationally acclaimed leader and scientist whose work has improved health care in the United States and globally. His seminal work in cardiovascular medicine and genetics laid the foundation for the development of the class of lifesaving drugs known as ACE inhibitors, used globally to treat hypertension and heart failure. Dr. Dzau pioneered gene therapy for vascular disease and was the first to introduce DNA decoy molecules to block transcriptions in humans in vivo. His pioneering research in cardiac regeneration led to the Paracrine Hypothesis of stem cell action and his recent strategy of direct cardiac reprogramming using microRNA. He maintains an active NIH-funded research laboratory.

Read more »

View Webcast



Critical Illness and AKI in COVID-19: What Have We Learned?

Date of Event: October 22, 2020
Time: 10:30 AM - 12:30 PM EDT
Session Type: Simulive
Complimentary

During this session, experts in acute kidney care discuss challenges in caring for the most critically ill patients with COVID-19 and share lessons learned for care in future waves of the pandemic.

  • COVID-19 Associated AKI: Etiology and Pathophysiology - Kathleen D. Liu, MD, PhD, FASN
  • A Look Inside the COVID-19 ICU - Marlies Ostermann, MD, PhD
  • What's Old Is New: PD for AKI - Mihran V. Naljayan, MD, FASN

View Webcast



Policy in a Post-COVID World, Including the Christopher R. Blagg, MD, Endowed Lectureship in Kidney Diseases and Public Policy

Date of Event: October 22, 2020
Time: 5:00 PM - 6:45 PM EDT
Session Type: Live
Complimentary

This session examines the role of policy and policymakers at the federal, state, and local levels in the context of COVID-19. It delves into lessons learned about policies that were successful versus unsuccessful in the immediate response, strengths and weaknesses in our existing healthcare infrastructure and how those can improve, and what lasting implications COVID-19 will have on nephrology health policy.

  • Kidney Care and the COVID-19 Experience: The Christopher R. Blagg, MD, Endowed Lectureship in Kidney Diseases and Public Policy - Nicole Lurie, MD
  • Footing the Bill: Reliance on Private Institutions to Address Health Crises - Mary E. Klotman, MD, Paul E. Klotman, MD
  • Implementing Antiracist Kidney Care - Keisha L. Gibson, MD, MPH, FASN
  • Panel Discussion and Q&A

View Webcast



Speaker Bio

Homer W. Smith Award Lecture "Understanding Cellular Oxygen-Sensing Mechanisms: Implications for Medicine"

Peter J. Ratcliffe, MD, PhD

Date of Event: October 23, 2020
Time: 9:00 AM - 9:30 AM EDT
Session Type: Simulive
Complimentary

Speaker Bio

Sir Peter Ratcliffe grew up in north Lancashire and won an open scholarship to study medicine at Gonville and Caius College, Cambridge. He undertook clinical training at St. Bartholomew's Hospital, London, and after series of posts at the London postgraduate hospitals, moved to Oxford to train in nephrology. In 1990 he obtained a Wellcome Trust Senior Fellowship to work on cellular responses to hypoxia, retrained in molecular biology and founded a new laboratory working on hypoxia biology in cancer and circulatory diseases. He was appointed Nuffield Professor and Head of the Nuffield Department of Clinical Medicine in 2003, a position he held until 2016. He is currently Director of the Target Discovery Institute, and a Distinguished Scholar of the Ludwig Institute for Cancer Research. He is a Fellow of the Royal Society and the Academy of Medical Sciences and is an honorary member of the American Academy of Arts and Sciences. In the 2014 New Year's Honours List, he was knighted for services to clinical medicine. His work was recognised by the award of the Nobel Prize for Physiology or Medicine 2019.

Read more »

View Webcast



Adapting Practice to a Pandemic: Focus on Home Dialysis and Kidney Transplantation

Date of Event: October 23, 2020
Time: 10:00 AM
Session Type: On-Demand
Complimentary

In this session, home dialysis experts highlight key opportunities, barriers, challenges, and solutions in the utilization of home dialysis and the care of individuals receiving home dialysis during the COVID-19 pandemic. The transplant community and its patients then talk about surviving the initial pandemic and how they are managing and coping afterwards.

  • Increasing Home Dialysis Utilization: Is COVID-19 a Catalyst for Change? - Edwina A. Brown, MD, MBChB
  • Telemedicine and Home Dialysis: Virtual Care Real Opportunities - Susie Q. Lew, MD, FASN
  • Clinical Management of the Kidney Transplant Recipient: The Known Unknowns - Sumit Mohan, MD, MPH, FASN
  • Making It Safe to Stay Safe: Safe Living Post-Transplant in the COVID-19 Era - Emily Blumberg, MD
  • A Patient's Pandemic Journey - Glenda V. Roberts

View Webcast



High-Impact Clinical Trials Presentations

Date of Event: October 23, 2020
Time: 10:30 AM - 12:30 PM EDT
Session Type: Live
Complimentary

This session showcases the best late-breaking abstracts that will have a significant impact on clinical practice.

  • Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes - George L. Bakris, Rajiv Agarwal, Stefan D. Anker, Bertram Pitt, Luis M. Ruilope, Peter Rossing, Peter Kolkhof, Christina Nowack, Patrick Schloemer, Amer Joseph, Gerasimos Filippatos
  • EMPEROR-Reduced: Empagliflozin and Outcomes in Heart Failure and Chronic Kidney Disease - Faiez Zannad
  • Sequential Treatment with Tacrolimus and Rituximab vs. Alternating Corticosteroids and Cyclophosphamide in Primary Membranous Nephropathy (PMN) - Gema Fernandez Juarez, Jorge E. Rojas-Rivera, Anne-Els van de Logt, Joana Justino, Angel M. Sevillano, Fernando Caravaca-Fontan, Ana Avila, Cristina Rabasco, Virginia Cabello, Marian Goicoechea, Luis F. Quintana, Irene Agraz, Ana M. Romera segorbe, Amir Shabaka, Mario Espinosa, Jesus Egido, Gerard J. Lambeau, Pierre M. Ronco, Manuel Praga
  • Global Phase 3 Clinical Trials of Vadadustat vs. Darbepoetin Alfa for Treatment of Anemia in Patients with Non–Dialysis-Dependent Chronic Kidney Disease - Glenn M. Chertow
  • Oral Intradialytic Nutritional Supplements and Mortality in Hemodialysis Patients: A Cluster-Randomized, Pragmatic Clinical Trial - Daniel E. Weiner, Karen M. Majchrzak, Cindy D. Kinnard, Hocine Tighiouart, Todd Marren, Eduardo K. Lacson, Doug Johnson
  • Reducing the Burden of Dialysis Catheter Complications: A National Approach (REDUCCTION) - Martin P. Gallagher, Sradha S. Kotwal, Girish S. Talaulikar, Nicholas A. Gray, Kevan Polkinghorne, Stephen P. McDonald, Alan Cass
  • Regional Citrate vs. Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy Among Critically Ill Patients with Acute Kidney Injury: A Randomized Clinical Trial - Alexander Zarbock, Mira Kuellmar, Detlef Kindgen-milles, Peter Rosenberger, Sean M. Bagshaw, John A. Kellum, Melanie Meersch
  • Effects of Dapagliflozin on Kidney Function, Cardiovascular Events, and All-Cause Mortality According to Cause of Kidney Disease in the DAPA-CKD Trial - David C. Wheeler, Bergur V. Stefansson, Ricardo Correa-Rotter, Glenn M. Chertow, Tom Greene, Fan Fan Hou, Niels Jongs, John McMurray, Peter Rossing, David Sjostrom, Robert D. Toto, Anna Maria Langkilde, Hiddo J. L Heerspink

View Webcast



Speaker Bio

Donald W. Seldin Young Investigator Award Lecture "From Genes to Mechanisms to Medicines: The Arc of Discovery for Kidney Diseases"

Anna Greka, MD, PhD

Date of Event: October 24, 2020
Time: 9:00 AM - 9:30 AM EDT
Session Type: Simulive
Complimentary

Speaker Bio

Anna Greka is a physician-scientist leading the translation of scientific discoveries from the laboratory to clinical trials. She is an associate professor at Harvard Medical School (HMS); an associate physician in the Renal Division in the Department of Medicine at Brigham and Women's Hospital (BWH); and the founding director of Kidney-NExT, a Center for Kidney Disease and Novel Experimental Therapeutics at BWH and HMS. Anna is also an institute member of the Broad Institute of MIT and Harvard, where she directs the institute's Kidney Disease Initiative. Greka holds an A.B. in biology from Harvard College and an M.D. and Ph.D. in neurobiology from HMS. She received her medical and scientific training in the Harvard-MIT program in Health Sciences and Technology in the laboratory of National Academy of Sciences member David Clapham, where she explored the role of TRP channels in neuronal growth cone motility.

Read more »

View Webcast



Speaker Bio

State-of-the-Art Lecture "Global Efforts to Curate the Genome"

Heidi L. Rehm, PhD

Date of Event: October 24, 2020
Time: 9:30 AM - 10:00 AM EDT
Session Type: Simulive
Complimentary

Speaker Bio

Heidi Rehm, a human geneticist and genomic medicine researcher, is medical director of the Clinical Research Sequencing Platform and an institute member at the Broad Institute. She is chief genomics officer in the Department of Medicine at Massachusetts General Hospital (MGH). She is also a professor of pathology at MGH, Brigham and Women's Hospital (BWH) and Harvard Medical School. She is a board-certified geneticist and leader in defining standards for the interpretation of sequence variants and a principal investigator of a major NIH-funded effort called ClinGen (Clinical Genome Resource), providing free and publicly accessible resources to support the interpretation of genes and variants. Rehm received her B.A. degree in molecular biology and biochemistry from Middlebury College before earning her M.S. in biomedical science from Harvard Medical School and Ph.D. in genetics from Harvard University. She completed her post-doctoral training with David Corey in neurobiology and a fellowship in clinical molecular genetics at Harvard Medical School.

Read more »

View Webcast



Promoting Excellence in the Prevention and Treatment of COVID-19 Related AKI

Date of Event: October 24, 2020
Time: 2:30 PM - 4:30 PM EDT
Session Type: Simulive
Complimentary

Drs. Mitra Nadim, Kathleen Liu, Dominick Santoriello, and Jay Koyner discuss excellence in the prevention and treatment of AKI in patients diagnosed with COVID-19. Lectures include a proposed list of pathways to build a foundational program that transforms the recognition and delivery of AKI care, reduces morbidity and mortality, and improves long-term outcomes. Drs. Jorge Cerda and Sarah Faubel moderate the event.

View Webcast



Speaker Bio

State-of-the-Art Lecture "RNA Biology and Medicine: A Journey of Unexpected Discovery" and 2020 ASN Business Meeting

Joan Steitz, PhD

Date of Event: October 25, 2020
Time: 9:00 AM - 9:30 AM EDT
Session Type: Simulive
Complimentary

Speaker Bio

As a college student in the 1960s, Joan Steitz never imagined herself as a top-flight scientist. Certainly, she was fascinated by science. She even assisted senior scientists in laboratories at the Massachusetts Institute of Technology, where she was befriended by James D. Watson, co-discoverer of the DNA double helix, and at the Max Planck Institute in Germany. But when it came time to choose a career path, she had never seen a female professor or head of lab. So, she never aspired to such goals. Today, Prof. Joan Steitz is one of leading scientists in her field. Steitz is best known for her pioneering work in RNA. She and her student Michael Lerner discovered and defined the function of small ribonucleoproteins (snRNPs) in pre-messenger RNA—the earliest product of DNA transcription—and was the first to learn that these cellular complexes (snRNPs) play a key role in processing messenger RNA by excising noncoding regions and splicing together the resulting segments. Her breakthroughs into the previously mysterious splicing process have clarified the science behind the formation of proteins and other biological processes, including the intricate changes that occur as the immune system and brain develop. Steitz earned her Ph.D. from Harvard in 1967. After completing postdoctoral work in Cambridge, England, she joined the Department of Molecular Biophysics and Biochemistry at Yale as an assistant professor and later became an associate and full professor, as well as chair of the department.

Read more »

View Webcast